Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-28 @ 3:50 AM
Study NCT ID:
NCT05790304
Status:
COMPLETED
Last Update Posted:
2025-03-25
First Post:
2023-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-25
First Submit QC Date:
None
Study First Post Date:
2023-03-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-24
Last Update Post Date:
2025-03-25
Last Update Post Date Type:
ACTUAL